Valeant Pharmaceuticals International (VRX): Q1 EPS of $0.99 may not be comparable to consensus...

|About: Valeant Pharmaceuticals ... (VRX)|By:, SA News Editor
Valeant Pharmaceuticals International (VRX): Q1 EPS of $0.99 may not be comparable to consensus of $0.96. Revenue of $856M (+51.5% Y/Y). (PR)